- Georgetown University School and Medicine, Washington, DC – MD
- Georgetown University Medical Center, Washington, DC – Categorical Internal Medicine Residency
- University of Wisconsin Hospital and Clinics, Madison, WI – Fellowship in Cardiovascular Medicine
- Brigham and Women’s Hospital, Division of Cardiovascular Medicine, Boston, MA – Clinical Cardiac Electrophysiology Fellowship
Dr. Lee L. Eckhardt is the Gary and Marie Weiner Professor of Cardiovascular Research and a faculty member in the Division of Cardiovascular Medicine within the Department of Medicine. As an electrophysiologist, Dr. Eckhardt treats a wide variety of arrhythmia conditions particularly conditions that cause ventricular arrhythmia or sudden death. She is an expert in inherited arrhythmia conditions and directs both clinical and basic science arrhythmia research projects related to these interests with an overarching goal of prevention of sudden cardiac death (SCD). She is co-director of the Inherited Arrhythmia Clinic and the Cardiac Arrest Prevention Program. Dr. Eckhardt serves as the Vice President of the Cardiac Electrophysiology Society (2020-2022) and the Heart Rhythm Society Fellowship Committee. She is an editorial board member of the Heart Rhythm Society Journal, Heart Rhythm Care Reports Journal and JACC: Clinical Electrophysiology.
Dr. Eckhardt’s clinical interests include electrophysiology, cardiac arrest prevention, inherited arrhythmias, and genetic cardiac conditions.
View Dr. Lee Eckhardt’s publications on NCBI My Bibliography
Dr. Eckhardt’s research interests are related to the study of the cellular mechanisms and electrophysiology of arrhythmia syndromes that cause sudden death. The goals in her lab are synergistic to her clinical practice and aim to advance the investigative platform to better understand diverse arrhythmia syndrome phenotypes and genotype relationships. She is a skilled basic laboratory scientist, examining the mechanisms by which mutations in ion channel genes lead to inherited arrhythmias by causing dysfunction at the molecular and cellular level. Her lab utilizes a variety of model systems for arrhythmia investigation including complex transgenic murine models, heart failure murine and swine models, and human induced-pluripotent stem cell derived cardiomyocytes (iPS-CMs). She has a long-standing interest is sudden arrhythmic death prevention and developing a deeper understanding of inherited sudden death syndromes, such as Long QT Syndrome, Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT), and undefined arrhythmia syndromes like Idiopathic VF. The Eckhardt lab is particularly interested in utilizing iPS based cellular platforms to model human arrhythmia. A significant emphasis of her research is to use iPS-derived cardiomyocytes (iPS-CMs) and are dedicated to uncover arrhythmia mechanism(s) with the purpose of creating a more accurate method to treat patient with Inherited Arrhythmic conditions. Moreover, her lab has used CRISPR gene editing (UW Gene Editing Core) in iPS cells to create or correct patient specific lines. Understanding the physiologic impact of gene editing is of great interest and relates to my lab’s goal of helping to create a physiologic iPS-CM and the overarching goal to better understand arrhythmia mechanisms toward a goal of prevention of sudden cardiac death.